KYNTRA BIO, INC. (KYNB) Gross margin 2019–2025
KYNTRA BIO, INC. (KYNB) gross margin by fiscal year — reported gross profit divided by reported revenue.
91.4%FY2025 · since FY2019: 99.6% → 91.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 91.4% | +43.9 pp |
| FY2024 | 47.5% | -44.1 pp |
| FY2023 | 91.5% | +5.9 pp |
| FY2022 | 85.6% | -8.9 pp |
| FY2021 | 94.5% | -0.4 pp |
| FY2020 | 95.0% | -4.6 pp |
| FY2019 | 99.6% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice